Developer docs
API playgroundTry for free, no card

Search company profiles

Rottapharm

Full company profile

uuid000bdj6

Namestring
Rottapharm
Websiteurl
rotta.com
Company typeenum
Private
Founded yearint
1980
Short descriptiontext

Rottapharm is a privately held Italian pharmaceutical company headquartered in Monza, with origins in a 1961 research laboratory and a 5,001–10,000 employee workforce. It is historically known for developing Nimesulide, a proprietary NSAID launched in Italy in the 1980s.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMonza, Italy
HQ citystring
Monza
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pharmaceutical manufacturing, drug development, independent research, anti-inflammatory drugs, Italian pharmaceuticals
Industry4 codes
PRIMARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYTLALACAD
Pharmaceutical & Biologics Frozen Storage (Ultra-Low/Deep-Freeze)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Rottapharm is a pharmaceutical company that originates from a small independent research laboratory founded in 1961 in Italy. It develops and manufactures drug products, with Nimesulide (an anti-inflammatory drug developed in Italy in the 1980s) being the specifically identified product in the source material. The company is structured as a private for-profit entity headquartered in Monza, Italy, employing 5,001–10,000 people.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Nimesulide
CategoryAnti-inflammatory pharmaceutical
Description

Nimesulide is an anti-inflammatory drug developed in Italy in the 1980s, associated with Rottapharm's research legacy. It is indicated for the treatment of inflammatory conditions. Specific indications and dosage forms are not described in the provided source.

No data
Peers8 records
TypeBroad incumbent
Description

European (Spanish) specialty pharmaceutical company focused on branded dermatology and specialty products. Comparable to Rottapharm in proprietary branded pharma strategy and EU-centric footprint.

TypeBroad incumbent
Description

Family-owned Italian pharmaceutical company with strong R&D, branded specialty pharma, and a respiratory/rare-disease focus. Comparable on private status, Italian manufacturing base, and research-driven branded-drug model.

TypeBroad incumbent
Description

Privately-held Italian pharmaceutical group with branded specialty products, manufacturing in Italy, and global distribution. Matches Rottapharm's combination of Italian heritage, branded focus, and large employee base.

TypeBroad incumbent
Description

Italian privately-held pharmaceutical company focused on branded specialty products and inhalation/CDMO services. Comparable to Rottapharm in proprietary pharma manufacturing and European distribution.

TypeBroad incumbent
Description

Privately-held Italian pharma group (part of Angelini Industries) with branded CNS and consumer health products. Comparable to Rottapharm via private ownership, Italian manufacturing, and branded Rx portfolio.

TypeRegional player
Description

Italian pharmaceutical manufacturer specializing in injectable and sterile drug product manufacturing. Comparable to Rottapharm on Italian manufacturing heritage and sterile/fill-finish capabilities implied by industrial scale.

TypeBroad incumbent
Description

Large global pharmaceutical manufacturer (formed via Mylan–Upjohn merger) with significant manufacturing in Italy and a broad specialty/generics portfolio. Comparable on European manufacturing scale and pharma ops.

TypeBroad incumbent
Description

Italian specialty pharmaceutical company headquartered near Milan with a branded prescription portfolio across Europe. Highly comparable to Rottapharm in therapeutic focus, Italian/European footprint, and mid-large operational scale.

Market position
Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rottapharm

Pharmaceutical Manufacturingrotta.com

Rottapharm is a privately held Italian pharmaceutical company headquartered in Monza, with origins in a 1961 research laboratory and a 5,001–10,000 employee workforce. It is historically known for developing Nimesulide, a proprietary NSAID launched in Italy in the 1980s.

Rottapharm firmographics

Firmographics
Name
Rottapharm
Website
https://rotta.com
Company type
Private
Founded year
1980
Headcount range
101–250 employees
Short description
Rottapharm is a privately held Italian pharmaceutical company headquartered in Monza, with origins in a 1961 research laboratory and a 5,001–10,000 employee workforce. It is historically known for developing Nimesulide, a proprietary NSAID launched in Italy in the 1980s.
Ownership category
akta.pro rank

Rottapharm industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAAAKAB
Drug Product Fill-Finish & Aseptic Manufacturing Services
SECONDARYHLAGAIAC
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
SECONDARYTLALACAD
Pharmaceutical & Biologics Frozen Storage (Ultra-Low/Deep-Freeze)

Keywords

  • Pharmaceutical manufacturing
  • Drug development
  • Independent research
  • Anti-inflammatory drugs
  • Italian pharmaceuticals

Where Rottapharm is headquartered

Location

Headquarters

HQ city
Monza
HQ country
Italy
HQ region
Europe

Markets served

Rottapharm business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Rottapharm product offering

Product offering

Core offering

Rottapharm is a pharmaceutical company that originates from a small independent research laboratory founded in 1961 in Italy. It develops and manufactures drug products, with Nimesulide (an anti-inflammatory drug developed in Italy in the 1980s) being the specifically identified product in the source material. The company is structured as a private for-profit entity headquartered in Monza, Italy, employing 5,001–10,000 people.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nimesulide Nimesulide is an anti-inflammatory drug developed in Italy in the 1980s, associated with Rottapharm's research legacy. It is indicated for the treatment of inflammatory conditions. Specific indications and dosage forms are not described in the provided source.

Companies that use Rottapharm

Customer profile

Ideal customer profiles2 records

Rottapharm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Rottapharm competitors and assessment

Company assessment

Broad incumbents

  • Almirall: European (Spanish) specialty pharmaceutical company focused on branded dermatology and specialty products. Comparable to Rottapharm in proprietary branded pharma strategy and EU-centric footprint.
  • Chiesi Farmaceutici: Family-owned Italian pharmaceutical company with strong R&D, branded specialty pharma, and a respiratory/rare-disease focus. Comparable on private status, Italian manufacturing base, and research-driven branded-drug model.
  • Menarini Group: Privately-held Italian pharmaceutical group with branded specialty products, manufacturing in Italy, and global distribution. Matches Rottapharm's combination of Italian heritage, branded focus, and large employee base.
  • Zambon: Italian privately-held pharmaceutical company focused on branded specialty products and inhalation/CDMO services. Comparable to Rottapharm in proprietary pharma manufacturing and European distribution.
  • Angelini Pharma: Privately-held Italian pharma group (part of Angelini Industries) with branded CNS and consumer health products. Comparable to Rottapharm via private ownership, Italian manufacturing, and branded Rx portfolio.
  • Mylan (now Viatris): Large global pharmaceutical manufacturer (formed via Mylan–Upjohn merger) with significant manufacturing in Italy and a broad specialty/generics portfolio. Comparable on European manufacturing scale and pharma ops.
  • Recordati: Italian specialty pharmaceutical company headquartered near Milan with a branded prescription portfolio across Europe. Highly comparable to Rottapharm in therapeutic focus, Italian/European footprint, and mid-large operational scale.

Regional players

  • Laboratorio Italiano Biochimico (L.I.B.): Italian pharmaceutical manufacturer specializing in injectable and sterile drug product manufacturing. Comparable to Rottapharm on Italian manufacturing heritage and sterile/fill-finish capabilities implied by industrial scale.

Market position

Customer concentration

Rottapharm social profiles

Digital presence

Rottapharm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rottapharm leadership team

Management profile

Number of profiles

Rottapharm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rottapharm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rottapharm

What does Rottapharm do?

Rottapharm is a pharmaceutical company that originates from a small independent research laboratory founded in 1961 in Italy. It develops and manufactures drug products, with Nimesulide (an anti-inflammatory drug developed in Italy in the 1980s) being the specifically identified product in the source material. The company is structured as a private for-profit entity headquartered in Monza, Italy, employing 5,001–10,000 people.

When was Rottapharm founded?

Rottapharm was founded in 1980. It employs 101 to 250 people.

Where is Rottapharm based?

Rottapharm is headquartered in Monza, Italy, in the Europe region.

Who are Rottapharm's main competitors?

Broad incumbents on record are Almirall, Chiesi Farmaceutici, Menarini Group, Zambon, Angelini Pharma, Mylan (now Viatris) and Recordati. Laboratorio Italiano Biochimico (L.I.B.) is listed as a regional player.

Does Rottapharm have an API?

No public API is recorded for Rottapharm.

What industry is Rottapharm in?

Rottapharm's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAAAJAG, Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces), with a secondary code of HLAAAKAB, Drug Product Fill-Finish & Aseptic Manufacturing Services. Its NAICS code is 325412 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals